ERBB2 and breast carcinoma: Triple negative breast cancer (TNBC), which comprises approximately 15% of all breast carcinomas [1], is defined as breast carcinoma that does not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor type 2 (HER2).